Bioclinica launches OnPoint Direct

Clinical Trial Management System (CTMS) for the mid-market and CRO sectors

May 25, 2016

Bioclinica®, Inc., a specialty clinical trials technology and services provider, today introduced OnPoint Direct, a Clinical Trial Management System (CTMS) geared toward mid-market biopharma and Contract Research Organizations (CROs). OnPoint Direct offers a cost-friendly pricing structure that empowers organizations to adopt a full-featured clinical trial management solution without the complex configuration, capital investment or perpetual licensing models customary of other systems.

“We recognize that some organizations run fewer studies, so we created a purpose-built CTMS just for them,” said Bioclinica’s Vice President of Product Management, eHealth Solutions, Ron Burns. OnPoint Direct is a SaaS-based rapid start version of Bioclinica’s OnPoint CTMS, which is used by large pharma companies and CROs around the globe to manage their clinical trials. “Bioclinica now provides organizations with a premier end-to-end study management tool that takes them from rapid study start-up, to study conduct, and on through to study close-out with efficiencies built into every step of the process,” Burns said.

OnPoint Direct is an out-of-the-box solution that shares all of the same core functionality as the original OnPoint, but with streamlined configuration, slashing ramp-up time and investment. The SaaS-based offering is delivered through Bioclinica’s secure eHealth Cloud™, which leverages the Bioclinica Cloud Transformation Gateway™, a secure standards-based integration exchange that connects its eClinical Platform to innovative third-party applications and industry data banks.

“Organizations can now get studies up and running in a matter of weeks compared to several months,” Burns said. “With OnPoint Direct we focused on workflows people are using every day, like those related to Microsoft Word, Excel, Outlook and SharePoint.  OnPoint Direct seamlessly integrates with this suite, creating a familiar and comfortable working environment.” The approach reduces training time and speeds adoption.

To kick-off the new OnPoint Direct offering, Bioclinica will be conducting demonstrations in its exhibit at the DIA Annual Meeting to be held on June 26-30 in Philadelphia. One of Bioclinica’s CTMS experts, Lynn Fraser, is participating in a panel discussion about using CTMS to facilitate collaboration.

Find out more about Bioclinica and its eHealth Solutions at www.Bioclinica.com, and on the Trial Blazers blog at http://www.bioclinica.com/blog, and on Twitter at http://twitter.com/bioclinica

About Bioclinica

Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized by three business segments to deliver focused service supporting multifaceted technologies. The Medical Imaging and Biomarkers segment provides medical imaging and cardiac safety services and includes a molecular marker laboratory. The eHealth Solutions segment comprises an eClinical technology platform and professional services along with safety and regulatory solutions. Under the Global Clinical Research segment, Bioclinica offers a network of research sites, patient recruitment-retention services, and a post-approval research division. The Company serves more than 400 pharmaceutical, biotechnology and device organizations – including all of the top 20 – through a network of offices in the U.S., Europe and Asia.
Learn more at www.bioclinica.com.